COSCIENS BIOPHARMA

We are a specialty biopharmaceutical company engaged in the development and commercialization pharmaceutical and diagnostic products. $CSCI

[COSCIENS BIOPHARMA @COSCIENSBio]

COSCIENS Biopharma Inc. Reconstitutes Board for Benefit of Shareholders

https://t.co/b5eiVvfdjg
$CSCI

[COSCIENS BIOPHARMA @COSCIENSBio]

COSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for the Upcoming Annual and Special Meeting of Shareholders

https://t.co/Js3hEH3YSE
$CSCI

[COSCIENS BIOPHARMA @COSCIENSBio]

COSCIENS Biopharma Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update

https://t.co/rMFTnkqGJ0
$CSCI #Therapeutics

[COSCIENS BIOPHARMA @COSCIENSBio]

COSCIENS Biopharma Inc. Appoints Global Consumer Products and Biosciences Executive, Anna Biehn as Chief Executive Officer

https://t.co/YhEXlmoTPi
$CSCI #therapeutics

[COSCIENS BIOPHARMA @COSCIENSBio]

COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update

https://t.co/QDg0Xh2BCq
$CSCI #Therapeutics

[COSCIENS BIOPHARMA @COSCIENSBio]

COSCIENS Biopharma Inc. Announces Successful Phase 1 Results Supporting Initiation of Phase 2a Clinical Efficacy Trial with Avenanthramides as a Potential Anti-Inflammatory Product

https://t.co/H5SvG9RWfo
$CSCI #CoSciencs

[COSCIENS BIOPHARMA @COSCIENSBio]

Advancing a Priority Pipeline Beyond Successful Base-Business

$CSCI #CoSciencs

[COSCIENS BIOPHARMA @COSCIENSBio]

Transforming Health Through Natural Based Products​

$CSCI #CoSciencs

[COSCIENS BIOPHARMA @COSCIENSBio]

Wishing you a #HappyNewYear filled with joy, new beginnings, and endless opportunities. Here’s to making 2025 your best year yet!

[COSCIENS BIOPHARMA @COSCIENSBio]

Stay in the loop with Cosciencs! Sign up for alerts and be the first to know about our latest updates.

https://t.co/27zYoCgcBK
#CoSciencs $CSCI

[COSCIENS BIOPHARMA @COSCIENSBio]

We are focused on leveraging our research and clinical development expertise to advance medicines that improve the quality of life of patients with significant unmet medical needs across a range of therapeutic areas.

$CSCI #CoSciencs

[COSCIENS BIOPHARMA @COSCIENSBio]

Establishing #COSCIENS as a global leader in the development and commercialization of therapeutic assets that have the potential to enhance the lives of patients in need.

https://t.co/jT4rN7D0Wa
$CSCI

[COSCIENS BIOPHARMA @COSCIENSBio]

Wishing you a peaceful and joyful holiday season.

#HappyHolidays

[COSCIENS BIOPHARMA @COSCIENSBio]

COSCIENS Biopharma Inc. Provides Corporate Update and Highlights Pipeline Prioritization

https://t.co/lWvVUb8Bg2
$CSCI #Therapeutics

[COSCIENS BIOPHARMA @COSCIENSBio]

We are a specialty biopharmaceutical company dedicated to advancing health and wellness through our innovative portfolio of cosmeceutical, nutraceutical, and pharmaceutical products.

https://t.co/jT4rN7D0Wa

[COSCIENS BIOPHARMA @COSCIENSBio]

COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs

https://t.co/b0cuW0p5Ko
$CSCI #Diagnostics #Therapeutics

[COSCIENS BIOPHARMA @COSCIENSBio]

COSCIENS Biopharma Announces Change to Board of Directors

https://t.co/qiEsuZdI1h
$CSCI #Diagnostics #Therapeutics

[COSCIENS BIOPHARMA @COSCIENSBio]

COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director

https://t.co/9E7RkYzjtQ
$CSCI #Diagnostics #Therapeutics

[COSCIENS BIOPHARMA @COSCIENSBio]

COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs

https://t.co/IEjMNUaWr8
$CSCI #Diagnostics #Therapeutics

[COSCIENS BIOPHARMA @COSCIENSBio]

COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

https://t.co/JfbrfRQDmD
$CSCI #Therapeutics